Literature DB >> 7788519

Asthma and related atopic disorders in outpatients attending an urban HIV clinic.

R Y Lin1, T S Lazarus.   

Abstract

BACKGROUND: Drug hypersensitivity and pruritic cutaneous disorders are common in human immunodeficiency virus (HIV)-infected patients. Systematic cross-sectional studies, detailing the pattern of atopic disease, however, have not been performed in patients with HIV infection.
OBJECTIVE: To analyze the relationships between atopic disease and factors relating to lifestyle, environment, gender, genetics, and HIV disease-associated immune cell depletion.
METHODS: CD4 cell counts and interview data were recorded in a survey of 136 adult patients attending a community hospital-based HIV outpatient clinic. The reported presence of various atopic and related conditions (including asthma, hay fever, otitis, sinusitis, and dermatitis) were analyzed for prevalence and associations with CD4 cell depletion, family atopy, and other factors using logistic regression.
RESULTS: Seventeen percent and 15% of patients claimed to have asthma and hay fever, respectively. Eleven percent claimed chronic nasal symptoms without known hay fever. A recent CD4 count > or = 200 cells/dL was significantly associated with current asthma (P = .01) and this association remained after adjusting for other significant factors. The mean recent log CD4 count for patients with current asthma was significantly higher than other patients (5.63 +/- .73 versus 4.92 +/- 1.38, P = .001). There was no association between rhinitis and CD4 cell depletion. Histories of recent sinusitis (24%) and ear infections (16%) were common, and were significantly associated with current hay fever +/- chronic nasal symptoms (P < .05). Chronic pruritic rashes or eczema were reported in 29% and were more frequent in those with CD4 counts < 200/dL. Family histories of either asthma or hay fever were significantly associated with several condition including hay fever +/- chronic nasal symptoms, otitis, drug allergy, chronic pruritic rashes or eczema, and asthma.
CONCLUSIONS: Although atopic disorders in the setting of HIV infection appear to have some clinical associations similar to that reported for the general population, asthma appears to have a predilection towards less severe CD4 cell depletion. The potential role of chronic rhinitis +/- family atopy as risk factors for sinusitis and otitis may be important because treatment of selected individuals with rhinitis may potentially decrease some paranasal disease-related morbidity in HIV infection.

Entities:  

Mesh:

Year:  1995        PMID: 7788519

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  11 in total

1.  Activation of naturally occurring lung CD4(+)CD25(+) regulatory T cells requires CD8 and MHC I interaction.

Authors:  Anthony Joetham; Katsuyuki Takeda; Nobuaki Miyahara; Shigeki Matsubara; Hiroshi Ohnishi; Toshiyuki Koya; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-12       Impact factor: 11.205

2.  HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.

Authors:  Allison A Lambert; Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Robert A Wise; M Bradley Drummond
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

3.  Association between HLA inheritance and asthma medication use in HIV positive children.

Authors:  Samuel B Foster; Ming Lu; Bruce Thompson; Kenneth C Rich; Larissa M Matukas; Rosemarie Mason; Robert Winchester; Kelly S MacDonald; William T Shearer
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

4.  Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.

Authors:  George K Siberry; Erin Leister; Denise L Jacobson; Samuel B Foster; George R Seage; Steven E Lipshultz; Mary E Paul; Murli Purswani; Andrew A Colin; Gwendolyn Scott; William T Shearer
Journal:  Clin Immunol       Date:  2011-10-30       Impact factor: 3.969

Review 5.  New insights into HIV-1-primary skin disorders.

Authors:  Filiberto Cedeno-Laurent; Minerva Gómez-Flores; Nora Mendez; Jesús Ancer-Rodríguez; Joseph L Bryant; Anthony A Gaspari; Jose R Trujillo
Journal:  J Int AIDS Soc       Date:  2011-01-24       Impact factor: 5.396

Review 6.  Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.

Authors:  M Bradley Drummond; Ken M Kunisaki; Laurence Huang
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

7.  Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study.

Authors:  Samuel B Foster; Kenneth McIntosh; Bruce Thompson; Ming Lu; Wanrong Yin; Kenneth C Rich; Hermann Mendez; Leslie K Serchuck; Clemente Diaz; Mary E Paul; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2008-06-10       Impact factor: 10.793

8.  Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice.

Authors:  D B Corry; G Grünig; H Hadeiba; V P Kurup; M L Warnock; D Sheppard; D M Rennick; R M Locksley
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 9.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 10.  The relationship between HIV infection and atopic dermatitis.

Authors:  Donald Rudikoff
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.